Ignite Creation Date:
2024-05-06 @ 6:48 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05780671
Status:
RECRUITING
Last Update Posted:
2023-08-04
First Post:
2023-03-13
Brief Title:
Oxygen in Migraine Treatment
Sponsor:
Ankara Ataturk Sanatorium Training and Research Hospital
Organization:
Ankara Ataturk Sanatorium Training and Research Hospital
Study Overview
Official Title:
The Effectiveness of Supplemental Oxygen Therapy in Patients Receiving Acute Migraine Treatment in the Emergency Department
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
IIn this study the investigators planned to investigate effectiveness of supplemental oxygen in patients 18-65 years who were diagnosed as headache related to migraine without aura in the emergency department ED
Patients who will be ordered standard migraine therapy 50 mg dexketoprofen and 10 mg metoclopramide HCl in 100 cc normal saline IV by the physician blind to research will be evaluated by the researchers before the treatment and patients met the study criteria will be included Included patients randomly divided to two group study group will receive supplemental oxygen with face mask for 1 hour
Patients visual analog score VAS will be measured at 0th 15th 30th and 60th minute of treatment If there will not be a 50 decrease at VAS score from the beginning patients will be examined again by the physician again Patients who will be ordered 100 mg tramadol as rescue therapy by the physician will be continued to observed VAS scores will be measured at 120th minute again
To avoid drug related bias patients who will be ordered any other drug for primary care or rescue treatment other than mentioned above will not be included into the study
Patients who will be ordered standard migraine therapy 50 mg dexketoprofen and 10 mg metoclopramide HCl in 100 cc normal saline IV by the physician blind to research will be evaluated by the researchers before the treatment and patients met the study criteria will be included Included patients randomly divided to two group study group will receive supplemental oxygen with face mask for 1 hour
Patients visual analog score VAS will be measured at 0th 15th 30th and 60th minute of treatment If there will not be a 50 decrease at VAS score from the beginning patients will be examined again by the physician again Patients who will be ordered 100 mg tramadol as rescue therapy by the physician will be continued to observed VAS scores will be measured at 120th minute again
To avoid drug related bias patients who will be ordered any other drug for primary care or rescue treatment other than mentioned above will not be included into the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None